It is well known that impaired insulin receptor (IRS)/AKT signaling leads to defective adipogenesis in obesity64,65 and contributes to increased inflammation, which, in turn, hinders glucose disposal, resulting in a compensatory rise in beta-cell insulin production and hyperinsulinemia.66 The gene discussed is AKT1; the disease is hyperinsulinism.